01—Abstract
Summary
Summary of the 8-K/A filed April 6, 2026. Cited figures are marked; the original filing is the authoritative source.
Agilent Technologies, Inc. filed an 8-K on April 6, 2026, primarily to disclose a Transition and General Release Agreement with Bret DiMarco, dated March 31, 2026.
While this filing doesn't contain typical financial results or operational updates, the agreement's existence suggests a departure or separation involving Mr. DiMarco, who may be a significant executive or board member. Investors should note that details of this agreement, such as severance packages or ongoing obligations, are not provided in this exhibit list. The filing also includes the standard Cover Page Interactive Data File.
02—Key points
Key Highlights
- Disclosure of a Transition and General Release Agreement with Bret DiMarco.
- Agreement dated March 31, 2026.
- Filing date of the 8-K is April 6, 2026.
- The primary purpose of the filing is to report this agreement as an exhibit.
- No financial statements or other operational updates are included in this specific filing item.
- Includes the standard Cover Page Interactive Data File in Inline XBRL format.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing?
The main purpose of this 8-K filing is to disclose a Transition and General Release Agreement between Agilent Technologies, Inc. and Bret DiMarco, dated March 31, 2026.
Does this filing include financial results or performance updates?
No, this specific filing (Item 9.01) only lists exhibits, and does not contain financial statements or updates on the company's operational performance.
Who is Bret DiMarco and what is the significance of this agreement?
The filing does not specify Bret DiMarco's role within Agilent Technologies, Inc. or the exact terms of the agreement. However, such agreements typically relate to executive departures or separations. Investors may need to refer to other filings or company communications for further context on Mr. DiMarco's position and the implications of this release.
04—Continue